Locally unlocks prodrugs by radiopharmaceutical in tumor for cancer therapy
Changlun Wang(Peking University), Zhibo Liu(First Affiliated Hospital of Zhengzhou University), Zexuan Ding, Xi‐Yang Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Junyi Chen(Peking University), Zihang Zhang(Peking University), Siyong Shen(Peking University), Senhai Zeng(Peking University), Mengxin Xu(Peking University)
Cited by 16
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
A corrosion-resistant RuMoNi catalyst for efficient and long-lasting seawater oxidation and anion exchange membrane electrolyzer
|Nature Communications|2023|483
Covalent targeted radioligands potentiate radionuclide therapy
|Nature|2024|165
A highly active and durable electrocatalyst for large current density hydrogen evolution reaction
|Science Bulletin|2019|84